SILO News and Press, SILO Pharma Inc From 06/04/24

Silo Pharma (NASDAQ: SILO) , a developmental-stage biopharmaceutical company focused on developing novel formulations and drug-delivery systems for traditional therapeutics and psychedelic treatments, has submitted a pre-Investigational New Drug (“pre-IND”) briefing package and meet...

Clinical roadmap unveiled for novel and proprietary intranasal PTSD treatment SARASOTA, FL, June 04, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel...

2024-05-23 10:04:37 ET More on Health Care Select Sector SPDR XLV: Healthcare Is Ripe For Buying, Despite Patent Cliff XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care Short interest in S&P 500 ...

Silo Pharma (NASDAQ: SILO) , a developmental-stage biopharmaceutical company focused on developing novel formulations and drug-delivery systems for traditional therapeutics and psychedelic treatments, is reporting on results from a study that has identified a potential new drug formulation that c...

The study has identified a potentially new drug formulation that could potentially extend the period of remission and prevent relapse in patients with depression. SARASOTA, FL, May 21, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company...

2024-05-21 08:26:04 ET More on premarket gainers & stock LM Funding America, Inc. (LMFA) Q1 2024 Earnings Call Transcript LM Funding America, Inc. (LMFA) Q4 2023 Earnings Call Transcript BriaCell falls on $5M stock offering LM Funding America mines 24.7 b...

Silo Pharma (NASDAQ: SILO) , a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced its planned attendance at a hybrid public meeting on June 27, 2024. The meeting ...

SARASOTA, FL, May 14, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic tr...

2024-04-25 08:13:17 ET Losers: Meta Platforms META -15% after Q1 earnings release . AGBA Group Holding Limited ( AGBA ) -13% . Marinemax HZO -11% after Q2 earnings release . Wimi Hologram Cloud ( WIMI ) -10% . International Business Mach...

2024-04-24 08:45:23 ET More on pre-market losers & stocks. ING: Still Too Cheap Despite Disappointing Results ING Groep NV (ING) Q4 2023 Earnings Call Transcript Palisade Bio stock rallies nearly 100% on colitis drug analysis Palisade Bio stock slides 8% ...